Publications 2026

Cuminetti V, Boet E, Heugel M, Konieczny J, Bernal A, Gomez MJ, Grimolizzi F, Vilaplana-Lopera N, Ferré M, Villatoro A, Pandey DP, Torroja C, Taman H, Paulssen RH, Vogl T, Heckman CA, Vik A, Giovinazzo G, van Gastel N, García P, Sánchez-Cabo F, Sarry JE, Arranz L (2026)
Succinate receptor 1 restricts hematopoiesis and prevents acute myeloid leukemia progression
Nat Commun, 17 (1)
DOI 10.1038/s41467-026-68906-2, PubMed 41644523

Publications 2025

Marhelava K, Fidyt K, Pepek M, Krawczyk M, Forcados C, Malinowska A, Swiderska B, Fernandez-Fuentes N, Czerwik N, Baranowska I, Krzywdzinska A, Sedek L, Slota L, Perkowski B, Villatoro A, Leray T, Lech-Maranda E, Menendez P, Inderberg EM, Wälchli S, Winiarska M, Firczuk M (2025)
LILRB1-directed CAR-T cells for the treatment of hematological malignancies
Leukemia, 39 (6), 1395-1411
DOI 10.1038/s41375-025-02580-z, PubMed 40186066

Publications 2023

Klee CH, Villatoro A, Casey NP, Inderberg EM, Wälchli S (2023)
In vitro re-challenge of CAR T cells
Methods Cell Biol, 183, 335-353
DOI 10.1016/bs.mcb.2023.06.003, PubMed 38548418

Villatoro A, Cuminetti V, Bernal A, Torroja C, Cossío I, Benguría A, Ferré M, Konieczny J, Vázquez E, Rubio A, Utnes P, Tello A, You X, Fenton CG, Paulssen RH, Zhang J, Sánchez-Cabo F, Dopazo A, Vik A, Anderssen E, Hidalgo A, Arranz L (2023)
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Nat Commun, 14 (1), 12
DOI 10.1038/s41467-022-35700-9, PubMed 36596811

Villatoro A, Cuminetti V, Bernal A, Torroja C, Cossío I, Benguría A, Ferré M, Konieczny J, Vázquez E, Rubio A, Utnes P, Tello A, You X, Fenton CG, Paulssen RH, Zhang J, Sánchez-Cabo F, Dopazo A, Vik A, Anderssen E, Hidalgo A, Arranz L (2023)
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Nat Commun, 14 (1), 3874
DOI 10.1038/s41467-023-39601-3, PubMed 37391415

Publications 2020

Villatoro A, Konieczny J, Cuminetti V, Arranz L (2020)
Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia
Front Cell Dev Biol, 8, 607
DOI 10.3389/fcell.2020.00607, PubMed 32754595

Publications 2017

Arranz L, Arriero MDM, Villatoro A (2017)
Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications
Blood Rev, 31 (5), 306-317
DOI 10.1016/j.blre.2017.05.001, PubMed 28495184